TY - JOUR
T1 - The price of autonomy
T2 - Should we offer individuals a choice of colorectal cancer screening strategies?
AU - van Dam, Leonie
AU - Kuipers, Ernst J.
AU - Steyerberg, Ewout W.
AU - van Leerdam, Monique E.
AU - de Beaufort, Inez D.
PY - 2013/1
Y1 - 2013/1
N2 - A difference between colorectal cancer screening and screening for most other types of cancer is that various screening methods are available. A choice between screening methods is common in the USA. Most European programmes currently offer a single screening method, since it is recommended that only screening strategies with sufficient evidence for a reduction in colorectal cancer mortality are introduced. Faecal occult blood testing is widely accepted in Europe, and evidence on the effectiveness of flexible sigmoidoscopy is increasing. The availability of multiple effective screening options warrants deliberation on whether individuals should be given a choice between strategies. In this Personal View, we present arguments in favour and against offering a choice of screening strategies, together with the evidence substantiating these views. We also focus on screening invitees' autonomy, which is a crucial parameter in the debate.
AB - A difference between colorectal cancer screening and screening for most other types of cancer is that various screening methods are available. A choice between screening methods is common in the USA. Most European programmes currently offer a single screening method, since it is recommended that only screening strategies with sufficient evidence for a reduction in colorectal cancer mortality are introduced. Faecal occult blood testing is widely accepted in Europe, and evidence on the effectiveness of flexible sigmoidoscopy is increasing. The availability of multiple effective screening options warrants deliberation on whether individuals should be given a choice between strategies. In this Personal View, we present arguments in favour and against offering a choice of screening strategies, together with the evidence substantiating these views. We also focus on screening invitees' autonomy, which is a crucial parameter in the debate.
UR - http://www.scopus.com/inward/record.url?scp=84871839460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871839460&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(12)70455-2
DO - 10.1016/S1470-2045(12)70455-2
M3 - Comment/debate
C2 - 23276372
AN - SCOPUS:84871839460
SN - 1470-2045
VL - 14
SP - e38-e46
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 1
ER -
